GlaxoSmithKline Pharmaceuticals (BOM:500660) 3-Year Revenue Growth Rate : 0.30% (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals 3-Year Revenue Growth Rate?

GlaxoSmithKline Pharmaceuticals's Revenue per Share for the three months ended in Dec. 2023 was ₹47.56.

During the past 12 months, GlaxoSmithKline Pharmaceuticals's average Revenue per Share Growth Rate was 1.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of GlaxoSmithKline Pharmaceuticals was 12.50% per year. The lowest was 0.30% per year. And the median was 4.40% per year.

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Pharmaceuticals's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's 3-Year Revenue Growth Rate falls into.

GlaxoSmithKline Pharmaceuticals 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

GlaxoSmithKline Pharmaceuticals (BOM:500660) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

GlaxoSmithKline Pharmaceuticals 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

GLAXO:India

Address

Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030

Website

https://www.gsk-india.com

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines